FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16–0 in favour.
İlaç Aralık 2016'da FDA onayına sunulmuştur ve Ekim 2017'de FDA Danışma Komitesi ilaç lehine 16-0 oy vermiştir.